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Abstract
Background: Clinical decision-making is the vehicle of health care provision, and level of involvement predicts
implementation and satisfaction. The aim of this study was to investigate the impact of decision-making
experience on recovery.
Methods: Data derived from an observational cohort study “Clinical decision making and outcome in routine
care for people with severe mental illness” (CEDAR). Adults (aged 18–60) meeting standardised criteria for severe
mental illness were recruited from caseloads of outpatient and community mental health services in six European
countries. After consenting, they were assessed using standardised measures of decision-making, clinical outcome
and stage of recovery at baseline and 1 year later. Latent class analysis was used to identify course of recovery,
and proportional odds models to investigate predictors of recovery stage and change.
Results: Participants (n = 581) clustered into three stages of recovery at baseline: Moratorium (N = 115; 19.8%),
Awareness/Preparation (N = 145; 25.0%) and Rebuilding/Growth (N = 321; 55.2%). Higher stage was cross-sectionally
associated with being male, married, living alone or with parents, and having better patient-rated therapeutic
alliance and fewer symptoms. The model accounted for 40% of the variance in stage of recovery. An increased
chance of worse outcome (change over 1 year to lower stage of recovery) was found for patients with active
involvement compared with either shared (OR = 1.84, 95% CI 1.15–2.94) or passive (OR = 1.71, 95% CI = 1.00–2.95)
involvement. Overall, both process (therapeutic relationship) and outcome (symptomatology) are cross-sectionally
associated with stage of recovery.
Conclusions: Patient-rated decision-making involvement and change in stage of recovery are associated. Joint
consideration of decision practise within the recovery process between patient and clinician is supposed to be
a useful strategy to improve clinical practice (ISRCTN registry: ISRCTN75841675. Retrospectively registered 15
September 2010).
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Background
A policy consensus has emerged internationally support-
ing a mental health system orientation around recovery
[1]. Converting this policy rhetoric into clinical practice
has proved challenging, partly because the policy is not
yet matched by a strong evidence base [2]. Syntheses are
now beginning to be published addressing the concept
of personal recovery [3] and its relation to outcome e.g.
quality of life [4], specific pro-recovery interventions
such as peer support [5], and implications for services
[6]. However, wide variation is evident in emerging prac-
tices across different national and regional mental health
systems [7]. The disparate commentaries on a recent
overview [8] highlights the challenges of identifying best
practice in supporting recovery.
More and different research is needed. Why different?
Best available evidence indicates the key processes in-
volved in recovery which are Connectedness (“community
integration” in North America, “social inclusion” in the
UK, continental Europe and Australia), Hope and opti-
mism about the future, a positive non-stigmatised Identity,
Meaning in life, and Empowerment—the CHIME Frame-
work [3]. This framework has been validated internation-
ally [9] and in current mental health service users [10],
and the five processes are all potential target outcome do-
mains for mental health services, yet the current evidence
base and practice does not support this orientation. To
illustrate this point, in England the National Institute for
Health and Clinical Excellence (NICE) produces clinical
guidelines for a range of disorders, including the schizo-
phrenia guideline updated in 2014 [11]. No clinical trial
evidence with primary clinical end-points involving any of
the CHIME processes was cited in the evidence summary.
Evidence about the relationship between clinical practice
and recovery support is needed.
The necessary scientific building blocks are becoming
available. Recovery measures have been developed [12, 13],
and trials with recovery outcomes as primary clinical end-
points are being published [14, 15]. However, an evidence
gap remains about the relationship between clinical pro-
cesses and recovery. Specifically, there is an absence of
empirical evidence about recovery and clinical decision-
making—the important process of treatment planning
jointly between clinician and patient.
Clinical decision-making is the primary vehicle of men-
tal health service delivery. Three levels of patient involve-
ment in decision-making have been described: informed,
shared and passive [16]. Passive decision-making occurs
when the clinician makes the decision for the patient.
Informed (or active) decision-making occurs when the
patient makes the decision, having received information
from the clinician. Shared decision-making (SDM) is
collaborative decision-making involving the sharing of
information and expertise by both participants.
Shared decision-making in mental health is widely rec-
ommended [11], despite being under-researched. A recent
systematic review identified only two randomised con-
trolled trials investigating shared decision-making [17],
and a Cochrane review identified that ‘further research is
urgently needed’ [18]. Despite the limited research base, it
is recommended that ‘a shared decision making approach
should be facilitated’ in adult mental health services [11].
In this study, the determinants of stage of recovery were
investigated, with a particular focus on the experience of
involvement in clinical decision-making. The aims are to
identify (1) the course of change in stage of recovery, (2)
cross-sectional predictors of stage of recovery, and (3)
predictors of 1-year change in the stage of recovery.
Methods
Design
The CEDAR Study is a naturalistic prospective longitu-
dinal observational study with bimonthly assessments
during a 12-month observation period [19]. The overall
aim of the CEDAR Study is to assess the scope and
quality of clinical decisions in the treatment of people
with severe mental illness, and the impact of clinical
decision making in routine care on patient outcome.
Participants and procedure
A total of 588 participants were recruited from caseloads
of outpatient and community mental health services at
six centres throughout Europe: Aalborg (Denmark),
Debrecen (Hungary), London (England), Naples (Italy),
Ulm (Germany) and Zurich (Switzerland). Inclusion cri-
teria: aged 18–60 years at intake; mental disorder of any
kind as main diagnosis established by case notes or staff
communication using SCID criteria; presence of severe
mental illness (defined as Threshold Assessment Grid
(TAG) [20] score of > =5 and illness duration > = 2 years);
expected contact with mental health services (excluding
inpatient services) during the time of study participation;
sufficient command of the host country’s language; cap-
able of giving informed consent. Exclusion criteria: main
diagnosis of mental retardation, dementia, substance use
or organic brain disorder; cognitive impairment severe
enough to make it impossible to give meaningful infor-
mation on study instruments; treatment by forensic psy-
chiatric services. After complete description of the study
to the subjects, written informed consent was obtained.
Clinical staff rated TAG to identify presence of severe
mental illness, and eligible patients were approached to
give informed consent. At baseline, patients nominated a
clinician closely involved in their treatment, and both
completed baseline measures. At 1-year follow-up, pa-
tients and staff completed all baseline measures again.
Bi-monthly, patients and staff were asked independently
about context, content and implementation of clinical
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decision making. They wrote down the most important
decision made at their last meeting, A list of predefined
topics with three possible responses (“not discussed”,
“discussed, no decision made” and “discussed, decision
made”) was presented to indicated what was discussed
in general in the selected meeting. Patients most fre-
quently indicated having discussed “medication”, whereas
staff reported “symptoms” most frequently, the third most
frequent topic was “family” for both.
Ethical committee approval was obtained in all sites.
Quality assurance in data collection was maximised by
thorough training sessions for all study workers con-
ducted by experts prior to the start of data collection,
with biannual booster trainings for study workers during
the data collection period. The characteristics of the
sample are shown in Table 1.
Measures
All measures were used in the local language. Existing
translations were used when available, otherwise the
measure was translated using intensive forward and
backward translation by experienced bilingual clinical
researchers following common standards [21]. All total
scores except for Clinical Decision-Making Involvement
and Satisfaction (CDIS) and Camberwell Assessment of
Need Short Appraisal Scale (CANSAS) were pro-rated
where 80% of items were completed.
Diagnosis was established at baseline from casenotes
by researcher-assessed Structured Clinical Interview for
DSM-IV Axis I Disorders—Clinical Version (SCID) [22].
Three patient-rated measures: 1. Stages of Recovery
Inventory (STORI) is a 30-item assessment resulting in
allocation to one of five stages of recovery [23]. Because
the original study and three replication studies [24–26]
found a 3-cluster solution better fitted the data, a sum-
mary score comprising three stages was used: a) Mora-
torium (withdrawal characterized by a profound sense
of loss and hopelessness), b) Awakening/Preparation
(emergence of hope and taking first steps to work on
recovery skills), c) Rebuilding/Growth (from actively
working towards a positive identity and goals to a full and
meaningful life). 2. Outcome Questionnaire-45 (OQ-45.2)
is a 45-item measure which provides an index of mental
health functioning, ranging from 0 (good outcome) to 180
[27]. Sub-scales are symptom distress (range 0 to 100),
interpersonal relations (0 to 44) and social role (0 to 36).
Psychometric properties are confirmed in many studies
with high internal consistency (.90) and test-re-test
reliability (.84 over 3-weeks [28]). 3. Manchester Short
Assessment of Quality of Life (MANSA) is a 16-item
assessment of quality of life ranging from 1 (low quality
of life) to 7 [29]. Correlations between subjective quality
of life scores on MANSA and Lancashire Quality of Life
Profile were 0.83 or higher, Cronbach’s alpha for satisfac-
tion ratings was 0.74.
Three staff-rated measures: 1. Global Assessment of
Functioning (GAF) is a staff-rated one-item global
measure of symptomatology and social functioning,
ranging from 1 (worst) to 100 (best) [30]. 2. Health of
the Nation Outcome Scale (HoNOS) is a staff-rated 12-
item assessment of social disability ranging from 48
(worst) to 0 (best) [31]. 3. Threshold Assessment Grid
(TAG) is a staff-rated seven-item measure of severity
(comprising Safety, Risk and Needs/Disabilities) of
mental illness ranging from 0 (low severity) to 24 (20),
and a score of 5 or more indicates severity [20].
Four measures rated by staff and patients: 1. Clinical
Decision-Making Involvement and Satisfaction (CDIS)
scale measures involvement and satisfaction experienced
with a specific decision, with versions rated by the ser-
vice user (CDIS-P) and staff (CDIS-S) [32]. The Satisfac-
tion sub-scale ranges from 1 (low satisfaction) to 5, and
the Involvement sub-scale has three categories: Active
(patient made the decision), Shared (decision jointly
made by staff and patient) and Passive (staff made the
decision). Note therefore that staff-rated passive involve-
ment indicates passive involvement by the service user,
i.e. active staff involvement. 2. The Clinical Decision
Making Style Scale (CDMS) [33] measured preferences
for decision making. Parallel patient (CDMS-P) and staff
(CDMS-S) versions rated on a five-point Likert scale.
Table 1 Sociodemographic and clinical characteristics of patient
participants (N = 581)
Study centre (n, %)
Ulm
London
Naples
Debrecen
Aalborg
Zurich
111
80
101
97
97
95
19.1
13.8
17.4
16.7
16.7
16.4
Gender (female) (n, %) 306 52.7
Age (years) (M, SD) 41.7 10.8
Married (n, %) 145 25.5
Ethnic group (White) (n, %) 549 94.5
Years in school (M, SD) 10.4 1.9
Living alone (n, %) 230 39.6
Paid or self-employed (n, %) 109 18.8
Receiving state benefits (n, %) 419 72.2
Illness duration (years) (M, SD) 12.5 9.3
Diagnosis (n, %)
Psychotic disorder
Mood disorder
Other
264
198
119
45.4
34.1
20.5
TAG (M, SD) 7.5 2.2
GAF (M, SD) 49.2 10.9
Abbreviations: M mean, SD standard deviation, TAG Threshold Assessment Grid,
GAF Global Assessment of Functioning
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CDMS sub-scales are: Participation in Decision Making
(PD), and Information (IN). 3. Helping Alliance Scale
(HAS) measures therapeutic alliance, with versions rated
by staff (HAS-S, five items) and patients (HAS-P, six
items) both ranging from 0 (low therapeutic alliance) to
10 [34]. 4. Camberwell Assessment of Need Short
Appraisal Scale (CANSAS) measures the presence of a
met or unmet need in 22 domains, with versions rated by
staff (CANSAS-S) [35] and patients (CANSAS-P) [35, 36].
Three summary scores are produced: unmet need, met
need and no need, each ranging from 0 (low) to 22.
Data analysis
To meet aim 1 (Stages of recovery), baseline STORI data
were analysed using latent class analysis (LCA) [37] to
identify adequate number of courses of recovery. In
LCA, the observed variation in the indicator variable
(stage of recovery) is ascribed to unobserved variation in
the sample. Inter-individual differences concerning item
response are explained by the existence of sub-groups
with distinct response patterns. To keep the number of
estimated parameters of the model within a reasonable
range, we pooled the six response categories of the 30
items of the original measure into two categories (“not
true now” and “true now”). Initial modelling involved
the estimation of a single latent growth curve model,
followed by the addition of a series of unconditional
models. Models are viewed and compared based on
practical considerations and information criteria to
determine the adequate number of latent classes. In
this study the models were compared using Bayesian
Information Criterion (BIC). Better fitting models
show a small BIC.
To meet aims 2 (Predictors of recovery stage) and 3
(Predictors of change in recovery stage), proportional
odds models [38] were used. This approach is an ex-
tension of logistic regression, and was used because
of the ordinal structure of the dependent variable. A
latent continuum is divided into sections, and thresh-
olds indicate to which observed category of the
dependent variable the latent value relates (one
threshold less than categories). The dependent variable
was coded as 1 =Moratorium, 2 = Awareness/Preparation,
3 = Rebuilding/Growth.
For aim 3, generalized estimating equations (GEN-
MOD procedure in SAS) were used to estimate the as-
sociation between 1-year change in recovery stage (1 =
improved (by one or two stages), 2 = no change, 3 = de-
teriorated (by one or two stages)) and baseline recovery
stage, baseline and 1-year follow-up clinical measures
and sociodemographic predictor variables. Several
models were fitted, and the ‘Quasi-likelihood under the
Independence model Criterion’ (QIC) statistic was used
to compare models, with smaller QIC indicating better
fit [39]. Analyses were conducted using Mplus software
package 6.1, SPSS 21 and SAS 9.2.
Results
A total of 581 participants self-rated stage of recovery
at baseline: 115 (19.8%) Moratorium, 145 (25.0%)
Awareness and preparation, 321 (55.2%) Rebuilding and
growth. At 1-year follow-up, 512 (88.1%) of the 581 re-
rated stage of recovery: 50 (9.8%), 153 (29.9%) and 309
(60.4%) respectively.
Completers of both measurement points did not differ
from non-completers (with only one completed meas-
ure) with respect to sex, age, ethnicity, years in school,
duration of illness, TAG and OQ-45 at T0. Completers
had a significantly higher functioning (GAF mean =
49.40 (SD = 10.49) vs. 46.68 (SD = 13.57); t = −9.97(556),
p = 0.002).
Stages of recovery
We investigated the adequate number of courses of re-
covery by means of the number of classes representing a
certain stage of recovery. Each stage of recovery maps
toa certain response pattern of STORI items (e. g. being
on a low recovery stage means high values in Moratorium
items and lower values in other items). The latent class
analysis of STORI data is shown in Fig. 1.
The three-stage model best fitted the data (compared
to the five-class solution for recovery suggested by the
original publication). This indicates that participants
answers in the measure clearly cluster only into one of
three stages of recovery, not in five (BIC = 21017.699).
Class 1: medium stage of recovery, Class 2: lower stage
of recovery, and Class 3: higher stage of recovery. The
average probability for allocation into one distinctclass
was 0.95 for class 1, 0.98 for class 2 and 0.97 for class 3.
Predictors of recovery stage
The cross-sectional predictors of stage of recovery are
shown in Table 2.
Higher stage of recovery was associated with being
male, married, living alone / with parents (versus with
others), not living in the Italian site (compared to those
living in the Switzerland site), and having better
patient-rated therapeutic alliance and fewer symptoms.
The model accounted for 40% of the variance in stage
of recovery.
Predictors of change
At 1 year follow-up, 80 participants (15.8%) had deterio-
rated (changed to a lower STORI stage), 296 (58.5%) had
no change, and 130 (25.7%) had improved (changed to a
higher STORI stage). The best model (QIC fit index
1289.2; other models not shown) of predictors of change
in stage of recovery is shown in Table 3.
Loos et al. BMC Psychiatry  (2017) 17:38 Page 4 of 8
Table 2 Baseline predictors of stage of recovery (n = 397)
B SE Wald Sig.
Threshold
STORI T0 = 1 −2.75 1.02 7.32 .01
STORI T0 = 2 −1.59 1.01 2.49 .12
Coefficients
Centre (vs Zurich) Ulm .24 .29 .68 .41
London .21 .48 .19 .67
Naples −1.03 .37 7.80 .01
Debrecen −.23 .35 .45 .50
Aalborg .13 .34 .14 .71
Age .01 .01 .82 .37
Gender (female vs. male) −.42 .18 5.56 .02
Ethnicity (white vs. not) −.49 .53 .86 .35
Years in school .08 .04 3.76 .05
Married (yes vs. no) .68 .29 5.56 .02
Living situation (alone vs other) .68 .27 6.50 .01
Living situation (with parents vs other) .86 .32 7.27 .01
Work status (employed vs not) .31 .25 1.63 .20
State benefits (no vs. yes) −.42 .27 2.46 .12
Duration of Illness .00 .01 .07 .79
GAF .01 .01 1.61 .21
HAS-P total .10 .04 5.25 .02
OQ-45 Interpersonal relations −.10 .02 37.65 .00
Social role −.08 .02 14.74 .00
CDMS Participation −.14 .15 1.41 .24
Information .02 .13 .02 .90
CDIS-P (vs Passive) Shared .13 .19 .44 .51
Active .41 .25 2.61 .11
Pseudo R2 = 0.40
Abbreviations: STORI stages of recovery inventory, GAF Global Assessment of
Functioning, HAS Helping Alliance Scale, OQ-45 outcome questionnaire, CDMS
Clinical Decision Making Style Scale, CDIS Clinical Decision-Making Involvement
and Satisfaction
Bold = p < 0.05
Table 3 Generalized estimating equation for change in stage of
recovery (n = 587)
Odds ratio
(95% Confidence interval)
p
Gender 0.77 (0.51–1.14) .19
Ethnicity (White vs. nonWhite) 0.86 (0.25–2.97) .82
Age 1.01 (0.99–1.03) .48
Years in school 1.01 (0.90–1.13) .88
Marital status (Married vs. not) 0.71 (0.44–1.12) .16
Work status (Employed vs. not) 1.39 (0.85–2.24) .19
OQ-total 0.99 (0.98–1.01) .43
CANSAS-P unmet needs 1.01 (0.94–1.09) .76
CDMS-P Participation 0.79−(0.60–1.04) .10
CDMS-P Information 1.08 (0.82–1.44) .58
CDIS-P Involvement
(0 = active, 1 = shared)
1.84 (1.15–2.94) .01
CDIS-P Involvement
(0 = active, 1 = passive)
1.71 (1.00–2.95) .05
CDIS-P Involvement
(0 = shared, 1 = passive)
0.93 (0.65–1.34) .69
MANSA 1.06 (0.82–1.29) .77
HAS-P 0.99 (0.86–1.14) .90
GAF 1.01 (0.99–1.03) .19
HONOS 0.98 (0.95–1.01) .25
Time (Baseline vs. 1 year) 1.19 (0.98–1.45 .08
Effects adjusted for all other appropriate effects in the model
Abbreviations: OQ-45 outcome questionnaire, CANSAS Camberwell Assessment
of Need Short Appraisal Scale, CDMS Clinical Decision Making Style Scale,
CDIS Clinical Decision-Making Involvement and Satisfaction, MANSA Manchester
Short Assessment of Quality of Life, HAS Helping Alliance Scale, GAF Global
Assessment of Functioning, HONOS Health of the Nation Outcome Scale
Bold = p < 0.05
Fig. 1 Latent class profiles for the three-class solution
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Only time-adjusted patient-rated decision involvement
was significantly associated with a change in stage of
recovery over 1 year. We found an increased chance for
worse outcome (change to lower stage of recovery) for
patients with active involvement compared with either
shared or passive involvement. Patients who experienced
active involvement compared to those with shared in-
volvement had a 1.84-fold increased risk for worse out-
come (p = .01), and compared to those with passive
involvement had a 1.71-fold increased risk for worse
outcome (p = .05). No significant interaction between
time and involvement was found.
Discussion
This multinational study on stages, predictors and change
in recovery has three findings. First, empirical data distin-
guish between three distinct stages of recovery, which can
be labelled as Moratorium (=cognitive, volitional and be-
havioral disengagement), Awareness/Preparation (=partial
subjective engagement) and Rebuilding/Growth (=full be-
havioral engagement). The instrument STORI was origin-
ally based on a 5-category framework [36], and our study
is consistent with three cluster-analytic studies [24–26] in
identifying three distinct and interpretable stages. This in-
dicates the need to develop treatment protocols which are
organised by these stages of recovery.
Second, specific clinical, sociodemographic and geo-
graphic variables have cross-sectional association with
stage of recovery. This adds more clarity to a comprehen-
sive and multi-level evidence base for personal recovery.
Compared to research into clinical recovery—the trad-
itional understanding of recovery, involving sustained
symptom amelioration and restoration of functioning—we
already find a development of a comprehensive evidence
base, including global epidemiological prevalence studies
[36] and randomised controlled trial evidence investigat-
ing biological, psychological and social intervention.
Third, patients rating active involvement (compared
with either passive or shared involvement in decision-
making) at baseline were more likely to have changed to
a lower stage of recovery 1 year later. This is a counter-
intuitive result at first glance. Experience by the patient
of active involvement is influenced by role expectations,
treatment context, information, and clinician behavior.
There is emerging evidence that more active decision-
making (even than initially preferred by the patient) is
associated with increased satisfaction and subsequent
decision implementation [40] and poorer involvement
and satisfaction in regard to treatment-related decisions,
compared with social and financial decisions [41]. Further-
more, a preference by clinicians for active rather than
shared or passive patient involvement in decision-making
is associated with reductions in patient-rated unmet need
1 year later [42].
One possible explanation would be that in the short
term, active involvement is experienced as positive and
empowering, whereas in the longer term (as in the current
study) active involvement is a marker of staff-patient rela-
tionships which are insufficiently partnership-based. How-
ever, our therapeutic alliance measure (HAS) was not a
significant predictor of change in stage of recovery. Thera-
peutic alliance was though a cross-sectional predictor of
recovery, consistent with other empirical studies in which
working alliance was a mediator of recovery [43].
The main strengths of the study are the large, varied,
multisite sample recruited within routine mental health
services. All patients were screened for severe mental
illness, enhancing generalizability to other mental health
systems. Multi-perspective assessments of decision-
making by both staff and patients were used. In this
naturalistic study, patients rated any type of decision
they made with their clinician [41, 44], rather than the
approach taken in some reviews [17] of restricting con-
sideration to medical treatment decisions.
Several limitations apply. The use of a convenience
rather than cohort sample in each site reduces repre-
sentativeness, due to factors such as clinician bias in
referral. More generally, optimal involvement in clinical
decision-making may also differ between people with
long-term mental health problems (as investigated
here) and acute medical contexts. Measures used were
patient and clinician self-report and did not include in-
dependent observer ratings of involvement style. The
choice of predictors was a selective process and we can-
not rule out that further variables might also influence
the course of recovery.
Conclusions
This study indicates that the relationship between involve-
ment in decision-making and subsequent recovery is com-
plex. The research implication of our study is that decision-
making involvement and recovery are associated, so merit
longitudinal investigation using standardised assessments
to understand the direction of any causal relationship. It is
plausible that the optimal level of involvement varies with
stage of recovery. Therefore, clinical implication arising
from this study to adapt patient involvement to changes in
recovery process and preferences.
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